SRF acquires Dupont's Dymel pharma propellant biz for $20mn
The company signed a definitive agreement with E I DuPont De Nemours and Company USA on December 31 for the transaction, SRF Ltd said in a filing to the BSE.
Jan 01, 2015, 21:20 PM IST
pharmaceutical applications